INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
RB

Ryan Barbara

DirectorCIK 0001827169

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells1 / 0
Max Insider Score41
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
RB
Ryan BarbaraDirector
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
6,518 sh
May 13, 2026May 14, 2026
traded May 13, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Indivior Pharmaceuticals, Inc.Director · Jan 7, 2026
17
RB
Ryan BarbaraDirector
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A
—
3,722 sh
Jan 26, 2026
Jan 28, 2026
traded Jan 26, 2026
+2d
SEC FORM 4

Evidence

41
RB
Ryan BarbaraDirector
INDVIndivior Pharmaceuticals, Inc.
Open-market purchase · 10b5-1 plan
BUY$27K
775 sh
Jan 5, 2026Jan 7, 2026
traded Jan 5, 2026
+2dSEC FORM 4

Evidence